Here at Texere we’ve woken from a stormy night to a grim, rainy morning. The editor typing this introduction is a particularly sodden specimen. Whether the weather at your end is equally grey, or your dampness is one of the soul; fear not, because in this bronzed, glimmering newsletter we are reaching for the sun. Lofty goals are the order of the day: next-gen inhalers, factory upgrades, and the rollout of mRNA vaccines.

Weekly Spotlight

Discover the Benefits of Integrated Systems

With examples drawn from industry case studies, the latest episode of #TalkingPharma will examine how #GoingConti is overcoming some of the traditional hurdles associated with using direct compression (DC) in batch mode. Everything you need to know about continuous DC is just a click away. Sign up today

mRNA: Reaching for the Sun
09/24/2021 | Maryam Mahdi
What milestones will define the next era in the mRNA story?
Seriously Y'all Stop It
09/22/2021 | Stephanie Sutton
Pharma wants to empower patients to make informed healthcare decisions, but patients also need to be protected from misinformation.
Lonza’s Cantonese Dream
09/21/2021 | Angus Stewart
Swiss firm Lonza is taking its investment in China to the next level with a manufacturing upgrade to its key site in Guangdong Province.
Lungs In Silico
09/16/2021 | Angus Stewart
Inhalers still don’t work as well as they should, but computational modeling is here to help.
Webinars: On Demand

Evolution of Analytical Techniques for Biopharmaceutical Drug Development
Available On-Demand

Critical Quality Attributes for supply of clinical plasmids for cell and gene therapy development
Available On-Demand

The side-effects of bad data in API development and manufacture
Available On-Demand

White papers
Toothpaste identification by FingerPrint

This application note shows that the Epsilon 4 is fully capable of identifying small differences in materials. The finger printing technique is applicable to all materials including liquids, powders and solids. Read more

Technology for combating counterfeit medicine

This white paper examines the issue of counterfeit drugs, reviewing the various types produced and the nature and range of the damage they cause. The report then focuses on analytical methods for tackling the problem, in particular the use of X-ray powder diffraction (XRPD). Read more

Special Promotions
Keeping up with the Talking Pharma chat show?

In the latest episode of #TalkingPharma, GEA experts and guests will examine how developments in direct compression (DC) are improving the production of oral solid dosage forms and the benefits of #GoingConti. Sign up today

A dedicated cell + gene therapy newsletter from The Medicine Maker team

Join 1,000s of peers from across the pharmaceutical, investment, and regulatory sectors for expert insight, analysis and words of wisdom on everything cell + gene therapy. Subscribe Now

Nominations are open for The Medicine Maker 2021 Innovation Awards.

Coming to our December issue of The Medicine Maker, the Innovation Awards 2021 will showcase the top technologies released throughout 2021. Have your say on who you think deserves a place in these much anticipated awards. Nominate today!

Complimentary Passes for Advanced Therapies Integrates 7 Oct 2021 Register Now

Join the senior industry leaders that drive and deliver the full potential of ATMPs at this inaugural one-day live-streamed event in collaboration with Cell and Gene Therapy Catapult. Register now

Must-See Events Worldwide

We work with event organizers from all around the world to help bring the pharma industry together, from large congresses to intimate meetings that fit around a table. Discover some of the events that we partner with and and stay up-to-date with the latest developments.

Find out more